![]() Want to read more stories about business in the North? Subscribe to our newsletter. The company remains on track for Vi to hit the market in 2023, he confirmed. “With this new method, we may be able to perform other, really sensitive, assays, (while) also making them available commercially,” said Sutton. The NSERC money is to primarily fund the labour costs to adapt Soleymani’s PSA test into Verv’s disposable test chip. He said it’s a “perfect fit” for their Vi analyzer. Soleymani has invented a unique lab method for quantifying certain types of biomarkers, such as PSA. The easy-to-use disposable testing device will help people measure a wide range of important analytes such as prostate-specific antigen (PSA), vitamin levels, cholesterol, glucose, and hormones. The Hamilton-based university has the world-class research infrastructure and testing facilities in place to help develop medical diagnostic devices.įormed in 2012, Verv has invented a method and device, dubbed Vi, that, with a finger prick of blood, separates the plasma from whole blood and conducts an analysis of the different biomarkers in your blood to deliver the results to your smartphone within minutes. ![]() Leyla Soleymani, a McMaster engineering physics professor and a Canada Research Chair in miniaturized biomedical devices. Verv will be working with a team fronted by Dr. ![]() The company announced last week it’s received $314,000 in federal NSERC (Natural Sciences and Engineering Research Council of Canada) funding to work with researchers at the Hamilton university to further take its blood analyzer product down the commercial development path. Verv Technologies, a Sudbury medical technology company, is teaming up with McMaster University in making accretive steps to bring a transformative home blood testing kit to market.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |